As a leading expert in biopharmaceutical research and development, Ivan Kairatov has spent his career at the forefront of medical innovation. Today, he joins us to discuss a significant breakthrough in the fight against the Epstein-Barr virus—a pathogen that infects an estimated 95% of the world's
Reprogramming the fundamental operating system of a cell by rerouting its intricate metabolic pathways is no longer a concept confined to theoretical biology; it is an rapidly advancing field with the power to correct life-threatening genetic defects at their core. Cellular metabolic engineering
In the high-stakes world of pharmaceutical development, a successful Phase 3 trial is typically a cause for celebration, yet Ocular Therapeutix's recent announcement for its wet AMD treatment, Axpaxli, was met with a starkly different reality. The drug achieved its primary endpoint with statistical
With a major breakthrough in psychedelic medicine, Compass Pathways' psilocybin-based therapy, COMP360, has delivered compelling Phase 3 results, sending shockwaves through the biopharma world and reigniting hope for patients with treatment-resistant depression. To unpack what this means for
The journey through pediatric cancer treatment is a formidable one, marked not only by rigorous medical procedures but also by the often-unseen burdens of persistent pain, anxiety, and profound emotional distress. For countless children and their families, these psychological challenges are a daily
For many individuals diagnosed with life-threatening blood cancers, the search for a suitable stem cell donor becomes a desperate race against time, a journey where hope can dwindle with each passing day that a match is not found. The standard of care, an allogeneic stem cell transplant, relies
